A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results